Our team is trained in a range of disciplines, from analytical chemistry to medicinal chemistry and biochemistry, supported by experts in clinical studies and international registrations as per EMEA, US FDA Center for Biological Evaluation and Research, and ICH guidelines.
The InProPharma team of scientists has successfully developed and improved formulations of established products, and has developed and delivered technology transfers for the production of biologically active proteins, leading to product registration by our clients. |
|
The team is led by Dr. Ben Rademaker, the Founder and CEO of InProPharma BV. Dr. Rademaker is a medical biologist and holds a PhD in Mathematics and Natural Science from Vrije University in Amsterdam, Holland. In addition to setting up his own companies, he was the Director Corporate Drug Development, Rhein Biotech NV, Maastricht and the Green Cross Vaccine Company, Seoul, Korea. He is a member of the Dutch Pharmacological Society, the Federation of Innovative Drug Research (FIGON), and is a Registered Pharmacologist. Dr. Rademaker is the author of more than 50 scientific publications, and many regulatory affairs documents. |
